Atea Pharmaceuticals shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $568k | 106k | 5.38 |
| 2024-12-31 | $246k | 73k | 3.35 |
| 2024-09-30 | $200k | 60k | 3.35 |
| 2024-06-30 | $230k | 70k | 3.31 |
| 2024-03-31 | $271k | 67k | 4.04 |
| 2023-12-31 | $743k | 244k | 3.05 |
| 2023-09-30 | $289k | 96k | 3.00 |
| 2023-06-30 | $383k | 103k | 3.74 |
| 2023-03-31 | $457k | 137k | 3.35 |
| 2022-12-31 | $839k | 174k | 4.81 |
| 2022-06-30 | $321k | 45k | 7.09 |
| 2021-12-31 | $1.1M | 124k | 8.94 |
| 2021-06-30 | $1.4M | 65k | 21.46 |
| 2021-03-31 | $1.5M | 24k | 61.72 |
| 2020-12-31 | $593k | 14k | 41.78 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation